Bioassay Development Lead
Bill and Melinda Gates Medical Research Institute
Cambridge, Massachusetts
Enaksha has over 20 years of experience in Pharma R&D as a bioanalytical expert combined with ADME/DMPK project leadership. He is currently a Bioassay Development Lead at the Gates Medical Research Institute. Prior to that he served as a Research Advisor at Eli Lilly and Company where he was responsible for the development, validation, and execution of quantitative LC-MS/MS assays supporting the entire small molecule portfolio, spanning from discovery to registration. He is also an expert on novel blood sampling technologies and supporting Decentralized Clinical Trials (DCTs). Enaksha has numerous publications demonstrating the adoption of patient centric minimally invasive blood sampling for pharmacokinetics supporting global trials including pediatric and for routine testing such as the liver and chemistry panels. He is the co-chair of the AAPS Microsampling and Patient Centric Sampling discussion group. Enaksha represented PhRMA as a member of the ICH M10 Expert Working Group. He received his Ph.D. from the Pennsylvania State University and his undergraduate from the University of Peradeniya (Sri Lanka).
Disclosure information not submitted.
Keynote: ADC: Drug Development Challenges- What We are Measuring and What Does it Matter?
Tuesday, October 22, 2024
1:30 PM – 2:30 PM MT